H.R. 4093House118th Congress (2023-2025)In Committee

Remote Opioid Monitoring Act of 2023

AI-Generated Summary

Updated January 20, 2026 at 8:58 AM UTC

The Remote Opioid Monitoring Act of 2023 requires the U.S. Comptroller General to carry out a study, within 18 months of the law’s enactment, on how remote monitoring affects people who are prescribed opioids. The study’s findings must be reported to several House and Senate committees. The goal is to understand the benefits, costs, and usage of remote monitoring and to guide possible policy changes.

Key Provisions

The Comptroller General must conduct the study and deliver a report to the House Energy and Commerce Committee and the Senate Health, Education, Labor, and Pensions and Finance Committees within 18 months of enactment.
The report must evaluate scientific evidence on the effectiveness, patient outcomes, and potential cost savings of remote monitoring compared with no monitoring.
The report must detail how widely remote monitoring is currently used for opioid patients in the U.S. and abroad.
The report must offer recommendations to improve access, coverage, and availability of remote monitoring, including possible changes to federal health programs, and identify patient groups that would benefit most.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions

HouseCommittee Latest Action

Referred to the Subcommittee on Health.

Health Subcommittee

June 16, 2023

View full timeline

HouseIntro Referral

Introduced in House

June 14, 2023

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

June 14, 2023

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

June 16, 2023

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued June 14, 2023

118th CONGRESS

1st Session

H. R. 4093

IN THE HOUSE OF REPRESENTATIVES

June 14, 2023

Mr. Balderson (for himself and Ms. Kelly of Illinois) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids.

Short title

This Act may be cited as the Remote Opioid Monitoring Act of 2023.

Providing for a study on the effects of remote monitoring on individuals who are prescribed opioids

(a)

In general

Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate a report on the use of remote monitoring with respect to individuals who are prescribed opioids.

(b)

Report

The report described in subsection (a) shall include—

(1)

an assessment of scientific evidence related to the efficacy, individual outcomes, and potential cost savings associated with remote monitoring for individuals who are prescribed opioids compared to such individuals who are not so monitored;

(2)

an assessment of the current prevalence of remote monitoring for individuals who are prescribed opioids, including the use of such monitoring for such individuals in other countries; and

(3)

recommendations to improve availability, access, and coverage for remote monitoring for individuals who are prescribed opioids, including through changes to Federal health care programs (as defined in section 1128B of the Social Security Act (42 U.S.C. 1320a–7b)) and, if determined appropriate by the Comptroller General, an identification of cohorts of individuals who stand to benefit the most from remote monitoring when prescribed opioids.